Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DEDiCa: Lifestyle and Vitamin D in Breast Cancer
NCT02786875Phase 3Unknown
- Sponsor
- National Cancer Institute
- Start
- Nov 2016
- Primary completion
- Oct 2020
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial (2 arms), sponsored by National Cancer Institute. Primary endpoint: Recurrence of disease at study end at 33 months. Status: unknown.
Beyond the preview
Go deeper on NCT02786875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02786875.